1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNCI SBIR/STTR Omnibus Grant Solicitations (Parent SBIR [R43/R44]) is sponsored by National Cancer Institute (NCI), NIH. The NCI SBIR/STTR Omnibus Grant Solicitations support small businesses in developing and commercializing innovative technologies to improve cancer prevention, detection, and care, including therapeutics like cell-based therapies and other cancer-related technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NCI SBIR/STTR Omnibus Grant Solicitations - NCI NCI SBIR/STTR Omnibus Grant Solicitations The Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Omnibus Solicitations are intended to support small business innovation research across a broad spectrum of topic areas.
U.S. small businesses that have the research capabilities and technological expertise to contribute to the research and development missions of the awarding components identified in the Omnibus Solicitation are encouraged to submit investigator-initiated SBIR & STTR grant applications in response to the identified topics.
Applicants may also consider other areas of research within the mission of any of the awarding components and submit an SBIR & STTR application Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms continue to be eligible to apply to the CDC and NIH SBIR program and compete for up to 15% and 25% respectively of each agency's SBIR set-aside.
Omnibus Solicitation Opportunities This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.
SBIR Program: PA-27-100 (Clinical Trial Optional) NIH, CDC, and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44]) Standard Receipt Dates: September 5, 2026; January 5, 2027; April 5, 2027 STTR Program: PA-27-102 (Clinical Trial Optional) NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42]) Standard Receipt Dates: September 5, 2026; January 5, 2027; April 5, 2027 Online HTML Application Guide SF424 (R&R) Application Guide for SBIR/STTR Grant Applications (Version i) Annotated SF424 SBIR/STTR Form Set NIH Matchmaker - Use NIH Matchmaker to conduct keyword searches on a particular topic area to identify NIH Institutes or Centers (ICs) that have previously funded research area.
According to the current listing, eligibility includes: U. S. -based small businesses with 500 or fewer employees. SBIR permits venture capital ownership, while STTR requires collaboration with a non-profit research institution. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: up to $400,000 for one year; Phase II: up to $2.25 million for two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NCI SBIR/STTR Omnibus Grant Solicitations (Parent SBIR [R43/R44]) is funded by National Cancer Institute (NCI), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article